All the news Showing 10 of 11 articles from: National policyGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Lancet commission sets agenda for the elimination of viral hepatitis Keith Alcorn / 10 January 2019 Viral hepatitis leads to around 1.3 million deaths a year, approximately 257 million people are living with hepatitis B virus (HBV) and 71 million with hepatitis C virus (HCV). Viral hepatitis ... New hepatitis C infections among HIV-positive gay men drop by half after direct-acting antiviral roll-out in Netherlands Liz Highleyman / 17 February 2017 A little more than a year after the Netherlands instituted a policy allowing unrestricted access to direct-acting antivirals for the treatment of hepatitis C, researchers have already seen a dramatic decline in acute ... US Veterans Affairs and Australia show potential for rapid elimination of hepatitis C Keith Alcorn / 15 November 2016 If sufficient money is available to pay for direct-acting antivirals (DAAs), the US Veterans Affairs (VA) could cure the majority of veterans under its care of hepatitis C within three years, and ... ELPA launches Hep-CORE study; preliminary data from patient groups raise concerns about responses to HBV and HCV in Europe Keith Alcorn / 27 July 2016 The European Liver Patients Association (ELPA), in collaboration with a European research team, recently launched the Hep-CORE study to assess national responses to viral hepatitis in the region, collecting a preliminary dataset ... Cost of eliminating viral hepatitis needs to take into account social as well as medical burden of disease Keith Alcorn / 04 May 2016 Securing commitments from national governments to treat viral hepatitis, scale up prevention activities and aim for elimination of hepatitis B and C by 2030 will require a broad coalition of forces – ... Elimination of viral hepatitis by 2030 is now the goal, advocates say Keith Alcorn / 12 April 2016 Hepatitis advocates are to launch a push for a global campaign to eliminate viral hepatitis by 2030. The move is part of a drive to raise political commitment for tackling viral hepatitis. The ... Cost of comprehensive global viral hepatitis prevention and treatment effort might peak at $11 billion in 2025 Keith Alcorn / 15 September 2015 Reaching the World Health Organization’s proposed targets for viral hepatitis control by 2030 could require global funding of $11 billion per year by 2025, Stefan Wiktor of the WHO Hepatitis Programme told ... General practitioners urged to test for viral hepatitis in all patients with liver abnormalities Caspar Thomson / 29 July 2013 General practitioners in Europe need to be more alert for possible signs of viral hepatitis and test patients accordingly, the spokesperson for Europe’s liver disease specialists said on Friday. Speaking at a press ... WHO hepatitis report: almost two-thirds of countries lack a national strategy on viral hepatitis Keith Alcorn / 24 July 2013 A survey of World Health Organization member countries released ahead of World Hepatitis Day on 28 July shows that nearly two-thirds still have no national plan to combat hepatitis, despite a 2010 ... 'War on drugs' fuelling the hepatitis C epidemic among people who inject drugs Michael Carter / 30 May 2013 The global war on drugs has had a disastrous impact on the hepatitis C epidemic, a new report from the Global Commission on Drug Policy shows. The Negative Impact of the War on ... ← First12Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Access to medicines & diagnostics Hepatitis C elimination Models of care Finance, funding & health economics National policy European policy International policy Activism and civil society Pharmaceutical industry Social issues Conference news Email bulletin archive